(Q51483217)

5 April 2018

title

Simple measures to monitor beta-cell mass and assess islet graft dysfunction. (English)

1 reference

5 April 2018

author

Antonello Pileggi

4

1 reference

5 April 2018

Camillo Ricordi

8

1 reference

5 April 2018

Livio Luzi

9

1 reference

5 April 2018

author name string

Faradji RN

1

1 reference

5 April 2018

Monroy K

2

1 reference

5 April 2018

Messinger S

3

1 reference

5 April 2018

Froud T

5

1 reference

5 April 2018

Baidal DA

6

1 reference

5 April 2018

Cure PE

7

1 reference

5 April 2018

Alejandro R

10

1 reference

5 April 2018

language of work or name

English

0 references

publication date

6 December 2006

1 reference

5 April 2018

American Journal of Transplantation

published in

1 reference

5 April 2018

volume

7

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

303-308

1 reference

5 April 2018

Beta cell function and its relation to insulin action in humans: a critical appraisal

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Successful islet transplantation: continued insulin reserve provides long-term glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Beta-score: an assessment of beta-cell function after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Rescue purification maximizes the use of human islet preparations for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Nonparametric analysis of clustered ROC curve data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Accurate assessment of beta-cell function: the hyperbolic correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01620.X

10.1111/J.1600-6143.2006.01620.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17173660

1 reference

5 April 2018